葛兰素史克(GSK)今日盘前大涨5.57%,主要受业绩利好以及公司对未来发展前景的乐观展望所推动。
具体来说,葛兰素史克2024年第四季度每股调整后收益为0.59美元,高于分析师预期的0.43美元,同比下降17.13%。而季度销售额达104.04亿美元,也高于预期的95.79亿美元,同比增长3.37%。公司业绩表现不仅超出市场预期,而且在各业务板块均有良好的体现。
展望2025财年,葛兰素史克预计其营业额将以固定汇率计增长3%至5%,核心营业利润和核心每股收益也将分别增长6%至8%。该公司专业药品营业额将实现低双位数增长,普通药品营业额将保持基本稳定。尽管疫苗营业额可能出现小幅下滑,但总体来说,公司未来的发展前景依然保持乐观态势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.